HomeHealthcare & Life SciencesPharmaceuticals Colloids (Blood Plasma) Market

Asia Pacific Colloids (Blood Plasma) Market Size & Outlook, 2025-2033


Asia Pacific Colloids (Blood Plasma) Market Insights

  • As highlighted in Reed Intelligence analysis, the Asia Pacific Colloids (Blood Plasma) Market, valued at USD 739.51 Million in 2024, is estimated to achieve USD 1153.07 Million by 2033.
  • The market is estimated to grow at a CAGR of 5.08% spanning 2026 to 2033.
  • By market size, Natural Type Colloids led the By Type category in 2024.
  • The By Type segment led by Synthetic Type Colloids is estimated to post the fastest growth, sustaining its position as the most lucrative during the forecast timeframe.

Other Key Findings


  • The global Colloids (Blood Plasma) Market size saw Asia Pacific holding a share of 21.56% in 2024.
  • United States is forecasted to account for the leading share of the global market by 2033.
  • In Asia Pacific, Singapore is forecasted to be the fastest-expanding market, projected to reach USD 23.92 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 739.51 Million
Market Size In 2033 USD 1153.07 Million
Largest segment Natural Type Colloids
Units Revenue in USD Million
CAGR 5.08% (2025-2033)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
By Type
  1. Natural Type Colloids
  2. Synthetic Type Colloids
By Applications
  1. Extensive Burns
  2. Massive Blood or Plasma Loss
  3. Hypovolemic Shock 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports